Recent anecdotal reports have raised concern that delayed gastric emptying associated with GLP-1 receptor agonists can increase the incidence of regurgitation and subsequent aspiration of stomach contents during general anesthesia and deep sedation resulting in serious lung injury
As real-world evidence of GLP-1RA-associated tumor risk is very limited, we explored the association of GLP-1RA and all types of neoplasms by mining the FDA Adverse Event Reporting System (FAERS) database
Expanded therapeutic options are providing more and more patients with relief from chronic conditions, but innovation comes at a cost
Lead pipeline shows which prospects have converted to patients
There is a risk of mild diarrhoea, upset stomach, nausea, a feeling of pain and warm sensation at the site of the injection, a feeling or a sense of being swollen over the entire body, headache and joint pain
Im gonna get a little scientific here, if thats all right